Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review-Reference-Cited by-同舟云学术

Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review

Published:2019-09 Issue: Volume:135 Page:29-32
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Konstantina Thomopoulou,Konstantinos Rounis,Anastasios Koutsopoulos^ORCID,Anastasia Mala,Eleni Lagoudaki,Ioannis Sougklakos,Sofia Agelaki,Dimitris Mavroudis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. WHO histological classification of tumors of the thymus,2015

2. ESMO guidelines committee. Thymic epithelial tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Girard;Ann. Oncol.,2015

3. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy;Zimmer;Eur. J. Cancer,2016

4. Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors;Makariousa;Eur. J. Cancer,2017

5. A phase II study of pembrolizumab for patients with previously treated advanced thymic epithelial tumor;Chol;J. Clin. Oncol.,2017

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic epithelial tumor medical treatment: A narrative review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review;Diagnostics;2024-08-16

3. Peripheral nervous system immune-related adverse events due to checkpoint inhibition;Nature Reviews Neurology;2024-08-09

4. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

5. Chemotherapy versus chemotherapy plus immune checkpoint inhibitors for the first‐line treatment of unresectable thymic carcinoma: A multicenter retrospective study;International Journal of Cancer;2024-04-12